Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.020
+0.020 (2.00%)
At close: Oct 9, 2026, 4:00 PM EDT
1.074
+0.054 (5.29%)
After-hours: Oct 9, 2026, 7:16 PM EDT
Pliant Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
49
Market Cap
63.16M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.58M | -8.11M | -83.69% |
| Dec 31, 2022 | 9.69M | 2.11M | 27.91% |
| Dec 31, 2021 | 7.57M | -34.25M | -81.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Xilio Therapeutics | 64.09M |
| Gossamer Bio | 53.29M |
| Alps Group | 3.74M |
| RenovoRx | 1.98M |
| Mereo BioPharma Group | 500.00K |
| iBio, Inc. | 100.00K |
| NeOnc Technologies Holdings | 39.99K |
PLRX News
- 9 days ago - Pliant Therapeutics appoints David Raben as Chief Medical Officer - TheFly
- 9 days ago - Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer - GlobeNewsWire
- 7 weeks ago - Pliant Therapeutics receives Fast Track designation from FDA for PLN-101095 - TheFly
- 7 weeks ago - Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors - GlobeNewsWire
- 7 weeks ago - Pliant Therapeutics reports Q2 EPS (36c), consensus (34c) - TheFly
- 1 month ago - Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 1 month ago - Pliant Therapeutics Quarterly report: Q2 2026 - Filings
- 1 month ago - Pliant Therapeutics Earnings release: Q2 2026 - Filings